| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents (note 7) | 9,791,900 | 3,375,900 | 3,093,300 | 3,369,000 |
| Short-term investments (note 7) | 121,600 | 170,100 | 127,400 | 149,400 |
| Accounts receivable, net of allowances of 21.7 (2025) and 14.9 (2024) | 16,107,400 | 14,170,400 | 12,036,600 | 10,294,800 |
| Other receivables | 3,349,800 | 3,035,200 | 1,966,600 | 1,756,900 |
| Inventories (note 6) | 12,180,400 | 11,013,800 | 9,311,000 | 7,459,800 |
| Prepaid expenses (note 8) | 20,248,700 | 18,019,800 | 14,653,900 | 8,250,600 |
| Other current assets | 271,500 | 68,800 | 72,400 | 134,600 |
| Total current assets | 62,071,300 | 49,854,000 | 41,261,200 | 31,415,100 |
| Investments (note 7) | 2,808,300 | 3,207,400 | 3,222,700 | 3,200,200 |
| Goodwill | 5,898,000 | 5,770,500 | 5,770,500 | 5,768,400 |
| Other intangibles, net | 6,446,700 | 5,908,300 | 6,012,200 | 6,537,300 |
| Deferred tax assets | 8,962,700 | 9,427,400 | 8,573,200 | 7,392,300 |
| Property and equipment, net of accumulated depreciation of 12,410.9 (2025) and 11,789.0 (2024) | 22,316,000 | 20,529,700 | 18,474,100 | 16,171,800 |
| Other noncurrent assets | 6,432,400 | 6,225,300 | 6,074,900 | 5,121,800 |
| Total assets | 114,935,400 | 100,922,600 | 89,388,800 | 75,606,900 |
| Short-term borrowings and current maturities of long-term debt | 1,633,000 | 5,723,700 | 4,016,400 | 2,074,300 |
| Accounts payable | 4,262,200 | 4,075,700 | 3,442,000 | 2,886,500 |
| Employee compensation | 1,965,700 | 1,303,000 | 1,113,900 | 1,703,300 |
| Sales rebates and discounts | 17,620,200 | 14,537,400 | 11,550,300 | 12,429,700 |
| Dividends payable | - | 1,345,200 | 0 | 0 |
| Short-term income taxes payable | 9,444,400 | 6,958,000 | 6,175,700 | - |
| Other current liabilities | 5,215,400 | 5,076,900 | 3,769,800 | 5,580,300 |
| Total current liabilities | 40,140,900 | 39,019,900 | 30,068,100 | 24,674,100 |
| Long-term debt | 40,873,600 | 34,180,100 | 34,499,500 | 29,045,400 |
| Accrued retirement benefits (note 9) | - | 1,344,500 | 1,315,500 | 1,448,500 |
| Long-term income taxes payable | 6,293,600 | 5,684,300 | 5,370,500 | 3,878,800 |
| Other noncurrent liabilities | 3,776,500 | 2,344,700 | 2,288,400 | 2,239,400 |
| Total noncurrent liabilities | 50,943,700 | 43,553,600 | 43,473,900 | 36,612,100 |
| Common stock | 591,400 | 592,000 | 592,600 | 593,900 |
| Additional paid-in capital | 7,231,900 | 7,089,300 | 6,910,000 | 7,339,600 |
| Retained earnings | 22,252,000 | 17,376,200 | 15,099,500 | 13,627,200 |
| Employee benefit trust | 3,013,200 | 3,013,200 | 3,013,200 | 3,013,200 |
| Accumulated other comprehensive loss (note 11) | -3,206,300 | -3,716,000 | -3,774,600 | -4,274,800 |
| Cost of common stock in treasury | 62,500 | 55,400 | 49,500 | 32,700 |
| Total eli lilly and company shareholders' equity | 23,793,300 | 18,272,900 | 15,764,800 | 14,240,000 |
| Noncontrolling interests | 57,500 | 76,200 | 82,000 | 80,700 |
| Total equity | 23,850,800 | 18,349,100 | 15,846,800 | 14,320,700 |
| Total liabilities and equity | 114,935,400 | 100,922,600 | 89,388,800 | 75,606,900 |
ELI LILLY & Co (LLY)
ELI LILLY & Co (LLY)